MarketCapTrends
WHWK
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ · Healthcare

Whitehawk Therapeutics, Inc. Shareholder Equity 2018–2025

Whitehawk Therapeutics, Inc. annual/quarterly shareholder equity history from 2018 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.

  • Whitehawk Therapeutics, Inc. shareholder equity for the quarter ending December 31, 2025 were 136.3M, a 159.75% increase year-over-year.
  • Whitehawk Therapeutics, Inc. shareholder equity for 2025 were 136.3M, a 159.75% increase from 2024.
  • Whitehawk Therapeutics, Inc. shareholder equity for 2024 were 52.5M, a 50.11% decrease from 2023.
  • Whitehawk Therapeutics, Inc. shareholder equity for 2023 were 105.2M, a 33.58% decrease from 2022.
  • Whitehawk Therapeutics, Inc. shareholder equity for 2022 were 158.4M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Whitehawk Therapeutics, Inc. Annual Shareholder Equity (Millions of US $)
2025$136
2024$52
2023$105
2022$158
2021$136
2020$-12
2019$-9
2018$59
Whitehawk Therapeutics, Inc. Quarterly Shareholder Equity (Millions of US $)
2025-12-31$136
2024-12-31$52
2023-12-31$105
2022-12-31$158
2021-12-31$136
2020-12-31$-12
2019-12-31$-9
2018-12-31$59

Whitehawk Therapeutics, Inc. Shareholder Equity — FAQ

Whitehawk Therapeutics, Inc. (WHWK) shareholder equity over the last 8 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see WHWK's shareholder equity history?

The chart and table above show Whitehawk Therapeutics, Inc.'s shareholder equity by year and by quarter, including the growth rate.